Sionna Therapeutics, Inc.
SION
$37.17
-$0.15-0.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.80% | 18.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.81% | 8.67% | |||
| Operating Income | 0.81% | -8.67% | |||
| Income Before Tax | -0.80% | -12.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.80% | -12.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.80% | -12.23% | |||
| EBIT | 0.81% | -8.67% | |||
| EBITDA | 0.66% | -8.53% | |||
| EPS Basic | 0.07% | -11.89% | |||
| Normalized Basic EPS | 0.07% | -11.88% | |||
| EPS Diluted | 0.07% | -11.89% | |||
| Normalized Diluted EPS | 0.07% | -11.88% | |||
| Average Basic Shares Outstanding | 0.86% | 0.31% | |||
| Average Diluted Shares Outstanding | 0.86% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||